Blonanserin (Lonasen) is a relatively new atypical antipsychotic commercialized by Dainippon Sumitomo Pharma in Japan and Korea for the treatment of schizophrenia. Relative to many other antipsychotics, blonanserin has an improved tolerability profile, lacking side effects such as extrapyramidal symptoms and excessive sedation and hypotension.
5-HT Receptor Inhibitors Related Products:
RS-127445; Asenapine Maleate; WAY-100635 Maleate; WAY-100635 maleate salt; Vortioxetine; Vortioxetine hydrobromide; Intepirdine; Sertraline HCl; Lamotrigine; Azasetron hydrochloride; Iloperidone; Lasmiditan